Metformin for chemo-radio-sensitization of NSCLC

Radiother Oncol. 2016 Aug;120(2):363-4. doi: 10.1016/j.radonc.2016.06.018. Epub 2016 Jul 9.

Authors

Theodoros Tsakiridis¹, Heath Skinner², Gregory Pond³, Anand Swaminath¹, James Wright¹

Affiliations

¹ Radiation Oncology, Juravinski Cancer Center, Hamilton, Ontario, Canada; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
² Department of Radiation Oncology, M.D. Anderson Cancer Center, Houston, TX, USA.
³ Department of Oncology, McMaster University, Hamilton, Ontario, Canada.

PMID: 27401403
DOI: 10.1016/j.radonc.2016.06.018

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms
Metformin*

Substances

Metformin